| Literature DB >> 25184279 |
Mulualem Tadesse1, Gemeda Abebe1, Ketema Abdissa1, Alemayehu Bekele1, Mesele Bezabih1, Ludwig Apers2, Robert Colebunders3, Leen Rigouts4.
Abstract
BACKGROUND: Tuberculous lymphadenitis (TBLN) is the most common form of extrapulmonary tuberculosis. The cytomorphological features of lymph node smears have reduced specificity for the diagnosis of tuberculosis. The diagnosis of TBLN with direct smear microscopy lacks sensitivity due to the limited number of bacilli in lymph node aspirate. Therefore, we aimed to assess whether the concentration of lymph node aspirate improves the sensitivity of acid fast smear microscopy for the diagnosis of tuberculous lymphadenitis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25184279 PMCID: PMC4153659 DOI: 10.1371/journal.pone.0106726
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sensitivity and specificity of direct ZN stain, concentration method and cytology against culture (n = 187).
| Culture | Sensitivity% (95% CI) | Specificity% (95% CI) | |||
| Positive n(%) | Negative n(%) | ||||
|
| Positive (n = 25) | 44(97.8) | 1(2.2) | 34.6%(26.9–43.3) | 98.2(90.6–99.7) |
| Negative (n = 138) | 83(60.1) | 55(39.9) | |||
|
| Positive (n = 91) | 84(92.3) | 7(7.7) | 66.1(57.6–73.8) | 87.5(76.4–93.8) |
| Negative (n = 92) | 43(46.7) | 49(53.3) | |||
|
| Positive (n = 146) | 115(78.8) | 31(21.2) | 90.6(84.2–94.5) | 44.6(32.4–57.6) |
| Negative (n = 37) | 12(32.4) | 25(67.6) | |||
*CI = confidence interval.
Incremental yield of AFB grading on smears prepared after concentration as compared to direct smear microscopy at JUSH, Jimma, South West Ethiopia (n = 47).
| Grade on direct ZN method | Grade on concentration method | ||||
| Scanty | 1+ | 2+ | 3+ | Total | |
| Scanty | 3 | 14 | 9 | 0 | 26 |
| 1+ | 0 | 4 | 9 | 1 | 14 |
| 2+ | 0 | 0 | 1 | 4 | 5 |
| 3+ | 0 | 0 | 0 | 2 | 2 |
| Total | 3 | 18 | 19 | 7 | 47 |
Comparisons of cytomorphologic features with AFB positivity on direct and concentrated method of Z-N staining (N = 187).
| FNAC result | Total cases% (n/N) | Direct ZN staining | Concentrated ZN staining | ||
| Positive% (n/N) | Negative% (n/N) | Positive% (n/N) | Negative% (n/N) | ||
| TBLN | 79.7%(149/187) | 28.9%(43/149) | 71.1%(106/149) | 55.7%(83/149) | 44.3%(66/149) |
| Suppurative abscess | 7.0%(13/187) | 30.8%(4/13) | 69.2%(9/13) | 53.8%(7/13) | 46.2%(6/13) |
| Pyogenic infection | 5.3%(10/187) | 0.0%(0/10) | 100%(10/10) | 30.0%(3/10) | 70.0%(7/10) |
| Reactive LN | 4.3%(8/187) | 0.0%(0/8) | 100%(8/8) | 0.0%(0/8) | 100%(8/8) |
| Other diagnosis | 3.7%(7/187) | 0.0%(0/7) | 100%(7/7) | 0.0%(0/7) | 100%(7/7) |
*Reactive LN = Reactive lymphadenitis.
Correlation of cytomorphologic features of TBLN with AFB positivity (direct &concentrated smear) and culture positivity (N = 82).
| Cytological category | Cases% (n/N) | Direct ZN positive% (n/N) | Concentrated ZN positive% (n/N) | Culture positive% (n/N) |
| Epithelioid cell with necrosis | 39.0%(32/82) | 37.5%(12/32) | 53.1%(17/32) | 68.8%(22/32) |
| Epithelioid cell without necrosis | 12.2%(10/82) | 10.0%(1/10) | 40.0%(4/10) | 70.0%(7/10) |
| Necrosis without epitheloid cell | 36.6%(30/82) | 56.7%(17/30) | 73.3%(22/30) | 86.7%(26/30) |
| Polymorphs with necrosis | 12.2%(10/82) | 50.0%(5/10) | 60.0%(6/10) | 100%(10/10) |
Factors assessed for associated with smear positivity when considering concentration method alone in Jimma, southwest, Ethiopia.
| Factors | Concentration method (ZN) | OR[95%CI] | P-value | ||
| Positive | Negative | ||||
|
| Male | 57.6%(49/85) | 42.4%(36/82) | 1.8[1.0–3.4] | |
| Female | 43.1%(44/82) | 56.9%(58/82) | 1.0 | 0.20 | |
|
| 0–15 | 48.1%(13/27) | 51.9%(14/27) | 1.8[0.5–6.0] | |
| 15–30 | 47.3%(44/93) | 52.7%(49/93) | 1.8[0.7–5.1] | ||
| 30–45 | 61.7%(29/47) | 38.3%(18/47) | 3.2[1.1–9.9] | 0.51 | |
| >45 | 35.0%(7/20) | 65.0%(13/20) | 1.0 | ||
|
| Positive | 55.6%(5/9) | 44.4%(4/9) | 1.1[0.5–1.9] | |
| Negative | 50.0%(50/100) | 50.0%(50/100) | 1.0[0.3–4.3] | 0.924 | |
| Unknown | 48.7%(38/78) | 51.3%(40/78) | 1.0 | ||
|
| Cervical | 49.5%(54/109) | 50.5%(55/109) | 0.97[0.30–3.06] | 0.600 |
| Axillary | 48.6%(18/37) | 51.4%(19/37) | 1.00[0.28–3.60] | ||
| Inguinal | 64.3%(9/14) | 35.7%(5/14) | 2.10[.40–11.3] | ||
|
| ≤5 months | 48.7%(55/103) | 51.3%(58/103) | 1.05[0.37–2.99] | 0.360 |
| 6–10 months | 62.5%(20/32) | 37.5%(12/32) | 1.88[0.54–6.62] | ||
| 11–15 months | 39.1%(9/23) | 60.9%(14/23) | 0.52[0.14–1.97] | ||
| >15 months | 47.4%(9/19) | 52.6%(10/19) | 1.00 | ||
|
| Yes | 52.3%(57/109) | 47.7%(52/109) | 1.48[0.77–2.83] | 0.353 |
| No | 45.3%(34/75) | 54.7%(41/75) | 1.00 | ||
|
| Present | 63.6%(42/66) | 36.4%(24/66) | 2.52[1.30–4.89] | 0.003 |
| Absent | 42.1%(51/121) | 57.9%(70/121) | 1.00 | ||
|
| Purulent | 50.5%(54/107) | 49.5%(53/107) | 0.94[0.50–1.76] | 0.816 |
| Caseous | 48.8%(39/80) | 51.2%(41/80) | 1.00 | ||